{
	"formData": {"accrualType":"病人","nihFlg":"否","sponsorAddress":"陽明大學守仁樓316","genderEnum":"女","insuranceFlg":"有","croAddress":"croAddresscroAddress","accrualTaiwan":"92","title":"隨機、雙盲、多中心之臨床二期臨床試驗，以評估Imatinib於異體造血幹細胞移植後預防CMV感染","衛福部核准日期":"2018-09-20","locations":["門診處","病房"],"insuranceInst":"台灣人壽","crcNum":"crcNum","2-1.IRB核准日期":"2018-09-20","LAIs":[{"title":"主治醫師","name":"劉偉修","branch":"其他","email1":"au3232323232@mail.ndmctsgh.edu.tw"}],"AIs":[],"accrualGlobal":"92","proposedStartDate":"2018-06-08","accrualHospital":"0-16","protocolVersion":"Oscar test version Update","funds":["自籌(自行研究無經費補助，請說明如何自籌)"],"preview":{"emailPI":"AU674676463@mail.ndmctsgh.edu.tw","piAccountFlg":true,"titlePI":"主治醫師","branchPI":"其他","lastNamePI":"王甯祺"},"PI":[{"title":"主治醫師","name":"王甯祺","branch":"其他","email1":"AU674676463@mail.ndmctsgh.edu.tw"}],"nihReason":"測試案件nihReason","insuranceAmount":"200萬","dohApprovedNum":"","irbNum":"1-106-01-034","engTitle":"A Randomization, Double Blind, Multicenter Phase II Clinical Trial to Evaluate the Imatinib for Prophylaxis of CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation","dohFlg":true,"contractFlg":"否","proposedEndDate":"2018-06-08"}
}